Expression of PPIA in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

PPIA is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 3769.06

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

3088.7

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	7408.3
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	6760.9
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	6228.7
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	6105.4
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	5391.1
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	5182.9
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	4910.7
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	4833.8
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	4830.1
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	4435.5
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	4397.9
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	4382.0
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	4374.7
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	4339.8
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	4334.5
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	4278.3
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	4265.4
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	4166.5
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	4100.4
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	4095.8
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	4073.1
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	4045.0
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	4031.0
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	3999.5
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	3997.5
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	3943.8
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	3928.0
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	3834.1
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	3787.0
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	3751.1
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	3750.1
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	3734.8
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	3724.5
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	3721.2
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	3718.5
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	3702.9
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	3682.9
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	3646.2
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	3581.2
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	3560.1
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	3553.2
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	3547.2
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	3540.6
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	3484.6
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	3482.9
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	3473.2
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	3399.9
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	3380.6
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	3321.7
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	3315.1
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	3301.8
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	3295.1
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	3278.2
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	3254.0
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	3243.1
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	3157.4
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	3136.0
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	3135.9
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	3104.3
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	3062.1
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	3051.7
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	3046.8
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	3041.5
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	3038.4
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	3005.9
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	3005.8
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	3001.4
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	2995.4
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	2975.9
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	2920.0
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	2903.7
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	2886.3
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	2848.7
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	2820.0
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	2764.8
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	2745.0
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	2727.3
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	2725.8
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	2714.1
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	2711.4
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	2681.5
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	2676.6
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	2659.7
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	2650.3
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	2645.3
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	2627.0
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	2620.4
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	2619.1
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	2618.3
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	2595.4
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	2569.5
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	2567.1
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	2554.3
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	2534.3
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	2532.0
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	2514.6
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	2511.7
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	2493.3
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	2481.1
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	2465.6
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	2451.2
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	2450.4
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	2444.5
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	2439.4
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	2433.2
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	2363.0
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	2351.4
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	2346.6
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	2338.9
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	2320.3
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	2312.4
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	2285.5
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	2263.9
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	2262.5
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	2253.7
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	2197.0
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	2165.2
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	2150.0
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	2131.0
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	2108.2
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	2084.0
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	2082.7
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	2058.7
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	2051.4
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	2048.2
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	2024.9
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	1973.5
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	1936.1
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1897.5
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	1875.3
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	1839.7
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	1827.7
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1785.5
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	1750.0
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	1745.1
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	1714.0
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	1666.3
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	1633.3
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	1591.1
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	1531.5
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1283.6
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

PPIA is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 813.2

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

705.2

Number of samples

Samples

Sample	Description	pTPM
AK142	N, NA, stage:NA, alive, 90 days	1310.6
AK185	N, NA, stage:NA, alive, 330 days	1287.3
AK165	N, NA, stage:NA, alive, 360 days	1210.0
AK049	N, NA, stage:NA, dead, 180 days	1177.3
AK156	N, NA, stage:NA, dead, 330 days	1143.3
AK098	N, NA, stage:NA, dead, 660 days	1092.3
AK139	N, NA, stage:NA, dead, 270 days	1076.2
AK153	N, NA, stage:NA, dead, 240 days	1023.0
AK074	N, NA, stage:NA, alive, 300 days	990.1
AK216	N, NA, stage:NA, dead, 360 days	951.9
AK236	N, NA, stage:NA, dead, 360 days	944.8
AK173	N, NA, stage:NA, dead, 180 days	872.8
AK227	N, NA, stage:NA, alive, 300 days	864.8
AK231	N, NA, stage:NA, dead, 240 days	820.6
AK088	N, NA, stage:NA, dead, 360 days	816.1
AK072	N, NA, stage:NA, dead, 150 days	814.0
AK071	N, NA, stage:NA, dead, 540 days	812.4
AK100	N, NA, stage:NA, alive, 960 days	811.0
AK178	N, NA, stage:NA, dead, 240 days	804.3
AK149	N, NA, stage:NA, dead, 420 days	799.3
AK124	N, NA, stage:NA, alive, 1920 days	795.1
AK188	N, NA, stage:NA, alive, 420 days	791.2
AK199	N, NA, stage:NA, alive, 1860 days	786.6
AK066	N, NA, stage:NA, alive, 960 days	780.6
AK089	N, NA, stage:NA, dead, 330 days	769.5
AK158	N, NA, stage:NA, dead, 360 days	765.5
AK195	N, NA, stage:NA, dead, 390 days	764.2
AK213	N, NA, stage:NA, alive, 2010 days	749.0
AK053	N, NA, stage:NA, dead, 300 days	743.0
AK055	N, NA, stage:NA, dead, 240 days	723.6
AK003	N, NA, stage:NA, dead, 600 days	690.1
AK068	N, NA, stage:NA, alive, 360 days	669.1
AK051	N, NA, stage:NA, dead, 360 days	653.9
AK123	N, NA, stage:NA, dead, 180 days	651.3
AK183	N, NA, stage:NA, alive, 360 days	625.7
AK133	N, NA, stage:NA, dead, 360 days	612.4
AK041	N, NA, stage:NA, alive, 810 days	611.8
AK030	N, NA, stage:NA, dead, 120 days	585.0
AK081	N, NA, stage:NA, dead, 180 days	573.8
AK167	N, NA, stage:NA, dead, 180 days	563.7
AK076	N, NA, stage:NA, alive, 660 days	561.0
AK091	N, NA, stage:NA, dead, 210 days	549.5
AK099	N, NA, stage:NA, dead, 420 days	506.1
AK035	N, NA, stage:NA, dead, 210 days	471.9
AK015	N, NA, stage:NA, alive, 720 days	458.5
AK226	N, NA, stage:NA, dead, 360 days	455.2
AK002	N, NA, stage:NA, dead, 570 days	452.1
AK085	N, NA, stage:NA, alive, 660 days	441.6
AK218	N, NA, stage:NA, dead, 180 days	438.4
AK103	N, NA, stage:NA, alive, 1320 days	437.3
AK134	N, NA, stage:NA, dead, 360 days	429.9
AK079	N, NA, stage:NA, dead, 210 days	415.6
AK102	N, NA, stage:NA, alive, 1740 days	362.3
AK006	N, NA, stage:NA, dead, 360 days	352.9
AK117	N, NA, stage:NA, dead, 210 days	338.6
AK005	N, NA, stage:NA, dead, 240 days	266.8
AK043	N, NA, stage:NA, alive, 660 days	261.3
AK205	N, NA, stage:NA, dead, 120 days	180.1
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0218770003	Tumor	0.5
CPT0217100003	Tumor	0.5
CPT0204420003	Normal	0.5
CPT0221180003	Tumor	0.5
CPT0093360003	Tumor	0.4
CPT0206000004	Tumor	0.4
CPT0204330003	Normal	0.4
CPT0167640003	Tumor	0.3
CPT0205780003	Tumor	0.3
CPT0168830003	Tumor	0.3
CPT0087950003	Tumor	0.3
CPT0204360003	Normal	0.3
CPT0204380003	Normal	0.3
CPT0204400003	Normal	0.3
CPT0204350003	Normal	0.3
CPT0162020003	Tumor	0.3
CPT0093590003	Tumor	0.3
CPT0078580003	Tumor	0.3
CPT0204410003	Normal	0.3
CPT0204340003	Normal	0.3
CPT0204390003	Normal	0.3
CPT0217880003	Tumor	0.2
CPT0206230003	Tumor	0.2
CPT0189460003	Tumor	0.2
CPT0204370003	Normal	0.2
CPT0093510003	Tumor	0.2
CPT0092440003	Tumor	0.2
CPT0196850003	Tumor	0.2
CPT0207030003	Tumor	0.2
CPT0206880003	Tumor	0.1
CPT0168380003	Tumor	0.1
CPT0168270003	Tumor	0.1
CPT0167530003	Tumor	0.1
CPT0186100003	Tumor	0.1
CPT0199770003	Tumor	0.1
CPT0190360004	Tumor	0.1
CPT0093450003	Tumor	0.1
CPT0064650003	Tumor	0.1
CPT0089150003	Tumor	0.1
CPT0206780003	Tumor	0.1
CPT0219080004	Tumor	0.1
CPT0190240004	Tumor	0.1
CPT0125570003	Tumor	0.1
CPT0175060003	Tumor	0.1
CPT0218960004	Tumor	0.1
CPT0205570003	Tumor	0.1
CPT0206450003	Tumor	0.1
CPT0182580003	Tumor	0.1
CPT0125220003	Tumor	0.1
CPT0162140003	Tumor	0.1
CPT0228220003	Tumor	0.0
CPT0206330003	Tumor	0.0
CPT0123530003	Tumor	0.0
CPT0217060003	Tumor	0.0
CPT0217000004	Tumor	0.0
CPT0079790003	Tumor	0.0
CPT0208980003	Tumor	0.0
CPT0087680003	Tumor	0.0
CPT0189250003	Tumor	0.0
CPT0189650004	Tumor	0.0
CPT0225760003	Tumor	0.0
CPT0167750004	Tumor	0.0
CPT0167860004	Tumor	0.0
CPT0087730003	Tumor	0.0
CPT0206110003	Tumor	0.0
CPT0205890003	Tumor	0.0
CPT0167970003	Tumor	0.0
CPT0224390004	Tumor	0.0
CPT0205670004	Tumor	0.0
CPT0224600003	Tumor	0.0
CPT0002410011	Tumor	0.0
CPT0218690004	Tumor	0.0
CPT0162100003	Tumor	0.0
CPT0209440003	Tumor	0.0
CPT0127480003	Tumor	0.0
CPT0104330003	Tumor	-0.1
CPT0064890003	Tumor	-0.1
CPT0104220003	Tumor	-0.1
CPT0168480003	Tumor	-0.1
CPT0217430008	Tumor	-0.1
CPT0168080003	Tumor	-0.1
CPT0125510003	Tumor	-0.1
CPT0093550003	Tumor	-0.1
CPT0071100003	Tumor	-0.1
CPT0218670003	Tumor	-0.1
CPT0225730003	Tumor	-0.1
CPT0206560003	Tumor	-0.1
CPT0189750004	Tumor	-0.1
CPT0189850004	Tumor	-0.1
CPT0217710008	Tumor	-0.1
CPT0201710003	Tumor	-0.1
CPT0218890004	Tumor	-0.1
CPT0168720003	Tumor	-0.1
CPT0205450004	Tumor	-0.1
CPT0087570003	Tumor	-0.2
CPT0218330004	Tumor	-0.2
CPT0182550003	Tumor	-0.2
CPT0216920008	Tumor	-0.2
CPT0189570004	Tumor	-0.2
CPT0206670004	Tumor	-0.2
CPT0224330003	Tumor	-0.2
CPT0207090003	Tumor	-0.2
CPT0182500003	Tumor	-0.2
CPT0218830004	Tumor	-0.2
CPT0217190003	Tumor	-0.3
CPT0171580008	Tumor	-0.3
CPT0168590003	Tumor	-0.3
CPT0161730003	Tumor	-0.3
CPT0127420003	Tumor	-0.3
CPT0224540004	Tumor	-0.4
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA058345	Antibody CAB004655
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, Low grade
Glioma, malignant, High grade
Glioma, malignant, NOS